| 000 | 00949 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515100400.0 | ||
| 264 | 0 | _c20071221 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCooke, Colin R | |
| 245 | 0 | 0 |
_aEpoetin alfa in critically ill patients. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cDec 2007 |
||
| 300 |
_a2516; author reply 2516-7 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aCritical Illness _xmortality |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 | _aEpoetin Alfa |
| 650 | 0 | 4 |
_aErythropoietin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 700 | 1 | _aRubenfeld, Gordon D | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 357 _gno. 24 _gp. 2516; author reply 2516-7 |
|
| 999 |
_c17593579 _d17593579 |
||